Ligand validation:3ZZS

TRP: TRYPTOPHAN

TRP is a Ligand Of Interest in 3ZZS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZZS_TRP_B_1072	100%	51%	0.048	0.989	0.91	0.98	1	-	1	0	100%	1
3ZZS_TRP_E_1072	99%	53%	0.047	0.983	0.79	1.01	-	-	1	0	100%	1
3ZZS_TRP_G_1072	99%	53%	0.051	0.982	0.82	0.99	-	-	0	0	100%	1
3ZZS_TRP_H_1072	99%	53%	0.052	0.981	0.79	1.02	-	-	1	0	100%	1
3ZZS_TRP_B_1073	99%	56%	0.054	0.982	0.83	0.88	1	-	1	0	100%	1
3ZZS_TRP_A_1072	98%	53%	0.054	0.978	0.86	0.95	-	-	0	0	100%	1
3ZZS_TRP_D_1072	98%	54%	0.053	0.973	0.8	0.98	-	-	0	0	100%	1
3ZZS_TRP_H_1073	98%	50%	0.058	0.976	0.83	1.09	-	2	1	0	100%	1
3ZZS_TRP_F_1072	97%	55%	0.057	0.97	0.81	0.94	-	-	1	0	100%	1
2EXS_TRP_B_1100	99%	49%	0.042	0.978	1.03	0.96	1	-	1	0	100%	1
5EF0_TRP_G_101	96%	41%	0.072	0.981	1.05	1.23	1	3	1	0	100%	1
1GTF_TRP_T_81	96%	48%	0.065	0.973	1.15	0.85	1	-	1	0	100%	1
2EXT_TRP_B_2100	95%	45%	0.082	0.988	1.11	1.02	2	-	1	0	100%	1
4V4F_TRP_AI_101	95%	48%	0.069	0.974	0.97	1.03	1	1	1	0	100%	1
3ZZQ_TRP_E_81	98%	50%	0.05	0.975	0.84	1.08	-	2	1	0	100%	1
6OS5_TRP_A_401	98%	49%	0.056	0.978	0.88	1.08	-	1	0	0	100%	0.9
2NW8_TRP_A_308	97%	57%	0.05	0.965	0.81	0.84	-	-	0	0	100%	1
7PI1_TRP_AAA_502	97%	53%	0.066	0.98	0.88	0.94	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.